NCT00006131View on ClinicalTrials.gov

Randomized Study of Two Doses of Oral Valacyclovir in Immunocompromised Patients With Uncomplicated Herpes Zoster

NACompletedINTERVENTIONAL

Enrollment

66

Participants

Timeline

Start Date

January 31, 1997

Conditions

Herpes ZosterImmunologic Deficiency Syndromes

Interventions

DRUG

Valacyclovir

Trial Locations (1)

77058

Center for Clinical Studies, Houston

All Listed Sponsors

collaborator

University of Texas

OTHER

lead

National Center for Research Resources (NCRR)

NIH